3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Malnutrition
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Colorectal Neoplasms
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcopenia
1
Polycystic Ovary Syndrome
1
Perioperative Complication
1
Obesity
1
Nutrition Disorders
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Food Preferences
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Diabetes, Gestational
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Body Weight Changes
1
Anosmia
1
Interventions
Cisplatin
160
Fluorouracil
134
Paclitaxel
125
Radiotherapy
117
Oxaliplatin
87
Carboplatin
71
Docetaxel
70
Irinotecan
59
pembrolizumab
57
Capecitabine
57
Leucovorin
56
Radiation
47
Surgical Procedures, Operative
33
Drug Therapy
33
Esophagectomy
31
Cetuximab
25
Neoadjuvant Therapy
24
Nivolumab
23
Bevacizumab
21
Trastuzumab
20
camrelizumab
19
S 1 (combination)
19
Chemoradiotherapy
17
Albumin-Bound Paclitaxel
16
Magnetic Resonance Spectroscopy
15
Epirubicin
15
tislelizumab
14
Taxes
13
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Esophageal Neoplasms
×
Nutrition Therapy
×
Clear all
NCT06414122
2025-03-19
MOMENT
University of Cologne
Phase NA
Not yet recruiting
88 enrolled